Loading...
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC) has been made over the past decade, the 5-year survival rate in patients with lung cancer remains only...
Na minha lista:
| Udgivet i: | Tuberc Respir Dis (Seoul) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771744/ https://ncbi.nlm.nih.gov/pubmed/29332322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2017.0120 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|